mRNA
AMCAP™ β-Galattosidase mRNA
Price range: 300,00 € through 1.700,00 €
AMCAP ™ mRNA is capped with Cap 1 structure and contains 100A tail in its sequence.
Description
AMCAP ™ β-Galactosidase mRNA expresses the β-Galactosidase enzyme, a widely used reporter gene in molecular biology.
β-Galactosidase catalyzes the hydrolysis of β-galactosides, such as lactose and X-gal. This mRNA is capped with a Cap1 structure with high capping efficiency and designed with a 100A tail to mimic mature mRNA. β-Galactosidase mRNA is a versatile tool that can be used to study a variety of biological processes, including gene expression, cell signaling, and enzyme activity. It is a valuable tool for researchers in a variety of fields, including molecular biology, cell biology, and biochemistry. This protein can be used to visualize gene expression or to measure enzyme activity. β-Galactosidase mRNA is a versatile tool for researchers studying a variety of biological processes. Its ability to produce β-Galactosidase makes it a valuable tool for studying gene regulation and cellular function.
Data & IP Statements
Products are not for resale without express written permission from Anemocyte s.r.l.
Any and all Intellectual Property Rights (means any and all rights in and to any and all intellectual property – whether registerable or patentable or not – including, but not limited to, names, trademarks, domain, trade names, designs, works of authorship, patents for inventions and utility models, processes, trade secrets, software, platforms, technology, know-how, sequencies and any other intellectual property) belong to Anemocyte s.r.l., which is their full, exclusive and unconditional owner, or are lawfully held or otherwise within legitimate possession or control of Anemocyte s.r.l.
No license under any patent or other Intellectual Property Rights of Anemocyte s.r.l. or its licensors is granted or implied by the purchase unless otherwise provided in writing.
Without prejudice to the foregoing, these products are manufactured using a Anemocyte s.r.l technology which is currently patent pending. Anemocyte s.r.l does not warrant that the use or sale of the products will not infringe the claims of any patents or patents pending, covering the use of the product alone or in combination with other products or in the operation of any process.
For further information contact sales@anemocyte.com
SEQUENCE
AMCAP™ β-Galattosidase mRNAFORMULATION
1 mM sodium citrate buffer (pH 6.4).
INTENDED USE
For Research Use Only. Not for use in humans. Not for use in diagnostic or therapeutic purposes. The purchaser has sole responsibility for all and any use of the products.
![](https://shop.anemocyte.com/wp-content/themes/ANEMOCYTE/img/download-cloud.svg")
Download Specification Sheet - R&D
